Hepion Pharmaceuticals, Inc. Share Price
Equities
HEPA
US4268973025
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | +6.20% | -31.84% | -57.72% |
04-22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
04-22 | Sector Update: Health Care | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 7.5M 600M |
---|---|---|---|---|---|
Net income 2024 * | -51M -4.08B | Net income 2025 * | -76M -6.08B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.13
x | P/E ratio 2025 * |
-
| Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.69% |
1 day | +6.20% | ||
1 week | -31.84% | ||
Current month | -44.98% | ||
1 month | -40.95% | ||
3 months | -25.54% | ||
6 months | -70.73% | ||
Current year | -57.72% |
Managers | Title | Age | Since |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 31/12/15 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 02/10/19 |
Stephen Kilmer
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 14/05/13 |
Timothy Block
BRD | Director/Board Member | 69 | 25/11/13 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 26/06/22 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.37 | +6.20% | 39,627 |
25/04/24 | 1.29 | -2.27% | 23,149 |
24/04/24 | 1.32 | -11.41% | 37,656 |
23/04/24 | 1.49 | +5.67% | 70,803 |
22/04/24 | 1.41 | -29.85% | 322,305 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.72% | 7.5M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- HEPA Stock